Synonym
Nithiamide; NSC 45914; NSC-45914; NSC45914
IUPAC/Chemical Name
2-Acetamido-5-nitrothiazole
InChi Key
UJRRDDHEMZLWFI-UHFFFAOYSA-N
InChi Code
InChI=1S/C5H5N3O3S/c1-3(9)7-5-6-2-4(12-5)8(10)11/h2H,1H3,(H,6,7,9)
SMILES Code
O=[N+](C1=CN=C(NC(C)=O)S1)[O-]
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
Biological target:
Nithiamide is a non-5-nitroimidazole drugs, is a antibiotic used in veterinary.
|
Solvent |
mg/mL |
mM |
comments |
| Solubility |
| DMF |
3.0 |
16.03 |
|
| DMSO |
10.0 |
53.43 |
|
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.
Preparing Stock Solutions
The following data is based on the
product
molecular weight
187.17
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Layton HW, Simkins KL, Eggert RG. Efficacy of nithiamide in preventing and treating swine dysentery in experimentally inoculated pigs. Am J Vet Res. 1977 May;38(5):627-31. PubMed PMID: 879561.
2: O'Shea JJ, Laurence A, McInnes IB. Back to the future: oral targeted therapy for RA and other autoimmune diseases. Nat Rev Rheumatol. 2013 Mar;9(3):173-82. doi: 10.1038/nrrheum.2013.7. Epub 2013 Feb 19. Review. PubMed PMID: 23419429; PubMed Central PMCID: PMC4169143.
3: Goodhew EB, Secor WE. Drug library screening against metronidazole-sensitive and metronidazole-resistant Trichomonas vaginalis isolates. Sex Transm Infect. 2013 Sep;89(6):479-84. doi: 10.1136/sextrans-2013-051032. Epub 2013 Jun 22. PubMed PMID: 23794105.
4: Kopteva LN. [Search for contact spermatocidal agents]. Akush Ginekol (Mosk). 1992 Feb;(2):67-70. Russian. PubMed PMID: 1476235.
5: Raynaud JP, Brunault G, Patterson EB. A swine dysentery model for evaluation of drug prophylaxis: efficacy of various drugs in the control of swine dysentery. Am J Vet Res. 1981 Jan;42(1):51-3. PubMed PMID: 7224318.
6: Beliaeva OA. [The treatment of intra-abdominal abscess]. Klin Khir. 1998;(7):32-3. Russian. PubMed PMID: 9989085.
7: ISSHIKI T, MASHIKO Y, NINOMYA M. On the polarography of 2-acetamido-5-nitrothiazole. Pharm Bull. 1954 Sep;2(3):256-8. PubMed PMID: 13215049.
8: Tarasenko SV, Aleksashina IP, Agapov VS, Trukhina GM, Liapunov NA. [The use of nitatsid and gipozol'-N in the combined treatment of acute inflammatory diseases of the maxillofacial area]. Stomatologiia (Mosk). 2000;79(2):17-9. Russian. PubMed PMID: 10812984.
9: KURNATOWSKA A. [Essay with 2-acetylamino-5-nitrothiazole in the treatment of vaginal trichomoniasis]. Wiad Parazytol. 1958;4(5-6):557-9; English transl 559-60. Polish, Portuguese. PubMed PMID: 13604196.
10: CAVIER R, SAVEL J, RUCART G. [Pharmacological study of a trichomonacidal drug: 2-acetylamino-5-nitrothiazole]. Therapie. 1958;13(3):502-7. French. PubMed PMID: 13603384.
11: FEO LG, FETTER TR. Evaluation of tritheon (aminitrozole) in male trichomoniasis. J Urol. 1958 Jul;80(1):72-4. PubMed PMID: 13564590.
12: BARNES J, BOUTWOOD A, HAINES E, LEWINGTON W, LISTER E, HARAM BJ. Oral treatment of trichomonas vaginitis with aminitrozole. Br Med J. 1957 May 18;1(5028):1160-2. PubMed PMID: 13426568; PubMed Central PMCID: PMC1973492.
13: HORTON-SMITH C, LONG PL. The effect of 2-amino-5-nitrothiazole, 2-acetylamino-5-nitrothiazole and furazolidone on the growth in vitro of Histomonas meleagridis. Ann Trop Med Parasitol. 1957 Mar;51(1):117-20. PubMed PMID: 13425322.
14: WILLCOX RR. Novobiocin, spiramycin, and aminitrozole in the treatment of non-gonococcal urethritis. Br J Vener Dis. 1957 Sep;33(3):180-1. PubMed PMID: 13471970; PubMed Central PMCID: PMC1054155.
15: BERTOLI PE. [2-acetylamino-5-nitrothiazole therapy of trichomonas vaginitis]. Minerva Ginecol. 1957 Dec 31;9(24):1006-10. Italian. PubMed PMID: 13516698.
16: Kalinichenko NF, Osolodchenko TP, Liapunov NA, Starobinets ZG. [Antibacterial activity of some trichomonacidal agents]. Antibiot Khimioter. 1990 Nov;35(11):34-7. Russian. PubMed PMID: 2092637.
17: WILLCOX RR. Treatment of vaginal trichomoniasis with aminitrozole and trichomycin given orally. Gynaecologia. 1960;149(Suppl):122-7. PubMed PMID: 13844789.
18: Tsarev VN, Ushakov RV. [The immunomodulating therapy of odontogenic phlegmons with complexes of antibacterial preparations and water-soluble polymers for medical use]. Stomatologiia (Mosk). 1996;Spec No:88. Russian. PubMed PMID: 9281191.
19: DUNLOP EM, PHILIPP E, WATT JD. Oral treatment of trichomonal vaginitis with 2-acetylamino-5-nitrothiazole (tritheon). Br J Vener Dis. 1958 Mar;34(1):57. PubMed PMID: 13523204; PubMed Central PMCID: PMC1047166.
20: BRET J. [Treatment of trichomonas vaginitis with oral & local 2-acetylamino-5-nitrothiazole]. C R Soc Fr Gyncol. 1958 Apr;28(4):218-25. French. PubMed PMID: 13573806.
